Alyeska Investment Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-346,171
| Closed | -$2.68M | – | 531 |
|
|
2022
Q3 | $2.68M | Sell |
346,171
-465,207
| -57% | -$3.6M | 0.03% | 298 |
|
|
2022
Q2 | $5.53M | Sell |
811,378
-36,539
| -4% | -$249K | 0.06% | 279 |
|
|
2022
Q1 | $6.76M | Hold |
847,917
| – | – | 0.07% | 258 |
|
|
2021
Q4 | $4.75M | Buy |
847,917
+26,895
| +3% | +$151K | 0.05% | 296 |
|
|
2021
Q3 | $6.31M | Buy |
821,022
+76,822
| +10% | +$591K | 0.08% | 279 |
|
|
2021
Q2 | $7.54M | Buy |
+744,200
| New | +$7.54M | 0.09% | 262 |
|